Synbiotic trial found an HDL cholesterol difference in children with obesity
A specific synbiotic favored HDL cholesterol compared with placebo, while body mass index scores and other metabolic measures showed no significant changes.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
In children with obesity, a synbiotic supplement changed HDL cholesterol more favorably than placebo over the study period. No significant changes were reported for other metabolic outcomes or the body mass index z-score. This narrow laboratory finding does not establish broader metabolic improvement or demonstrate a health benefit children would notice.
This abstract reports a short trial of a specific formulation. It does not establish lasting benefits, and the interval types accompanying its numerical HDL changes are not identified.
What researchers found
HDL cholesterol
At 3 months, HDL cholesterol change favored the synbiotic over placebo after adjustment for baseline values; the difference was statistically significant.
The shared support matters
Both groups received lifestyle counseling, so the trial tested the supplement alongside shared support. The product combined inulin with specified bacteria; the abstract provides no evidence that other synbiotic formulations would produce the same result.
A laboratory result has limits
Dietary intake and physical activity did not differ significantly between groups at follow-up. That describes the trial context, but it does not turn the isolated HDL finding into evidence of weight loss or lasting benefit.
The original publication
Effects of synbiotic supplementation on metabolic profiles in children with obesity: a randomized double-blinded placebo-controlled trial.
Charoensriwattanakul K, Visuthranukul C, Pongchaidacha P et al.
Nutr Metab (Lond) · 2026
- PubMed ID
- 41814326
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.